Portfolio company
Tango Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
IDEAYA Biosciences
This precision medicine company develops targeted oncology therapeutics for patients with solid tumours and molecularly defined cancers.
Bicara Therapeutics
This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.
Black Diamond Therapeutics
This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.
CARGO Therapeutics
This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.
Avenzo Therapeutics
This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.
PanCancerT
This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.
Fore Biotherapeutics
This precision oncology company develops targeted therapies for patients with unaddressed cancer mutations, including a specific BRAF inhibitor for advanced solid tumours.
Flamingo Therapeutics
This biotechnology company develops RNA-targeted therapies to treat various forms of cancer for patients with solid tumours.